Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2001 1
2003 2
2007 1
2008 1
2009 1
2010 2
2011 3
2014 1
2016 1
2018 1
2019 2
2020 3
2021 7
Text availability
Article attribute
Article type
Publication date

Search Results

26 results
Results by year
Filters applied: . Clear all
Page 1
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer.
Coleman RL, Fleming GF, Brady MF, Swisher EM, Steffensen KD, Friedlander M, Okamoto A, Moore KN, Efrat Ben-Baruch N, Werner TL, Cloven NG, Oaknin A, DiSilvestro PA, Morgan MA, Nam JH, Leath CA 3rd, Nicum S, Hagemann AR, Littell RD, Cella D, Baron-Hay S, Garcia-Donas J, Mizuno M, Bell-McGuinn K, Sullivan DM, Bach BA, Bhattacharya S, Ratajczak CK, Ansell PJ, Dinh MH, Aghajanian C, Bookman MA. Coleman RL, et al. Among authors: nicum s. N Engl J Med. 2019 Dec 19;381(25):2403-2415. doi: 10.1056/NEJMoa1909707. Epub 2019 Sep 28. N Engl J Med. 2019. PMID: 31562800 Free PMC article. Clinical Trial.
An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib.
Mateo J, Moreno V, Gupta A, Kaye SB, Dean E, Middleton MR, Friedlander M, Gourley C, Plummer R, Rustin G, Sessa C, Leunen K, Ledermann J, Swaisland H, Fielding A, Bannister W, Nicum S, Molife LR. Mateo J, et al. Among authors: nicum s. Target Oncol. 2016 Jun;11(3):401-15. doi: 10.1007/s11523-016-0435-8. Target Oncol. 2016. PMID: 27169564 Free article. Clinical Trial.
Colorectal cancer.
Nicum S, Midgley R, Kerr DJ. Nicum S, et al. Acta Oncol. 2003;42(4):263-75. doi: 10.1080/02841860310000412. Acta Oncol. 2003. PMID: 12899497 Review.
A source of hope for platinum-resistant ovarian cancer?
Blagden SP, Nicum S. Blagden SP, et al. Among authors: nicum s. Lancet. 2021 Jan 23;397(10271):254-256. doi: 10.1016/S0140-6736(21)00128-8. Lancet. 2021. PMID: 33485431 No abstract available.
Chemotherapy for colorectal cancer.
Nicum S, Midgley R, Kerr DJ. Nicum S, et al. J R Soc Med. 2000 Aug;93(8):416-9. doi: 10.1177/014107680009300807. J R Soc Med. 2000. PMID: 10983503 Free PMC article. Review. No abstract available.
Adenovirus retargeting and systemic delivery.
Seymour LW, Fisher KD, Green NK, Hale SJ, Lyons M, Mautner V, Nicum S, Onion D, Oupicky D, Stevenson M, Ulbrich K. Seymour LW, et al. Among authors: nicum s. Ernst Schering Res Found Workshop. 2003;(43):107-14. doi: 10.1007/978-3-662-05352-2_8. Ernst Schering Res Found Workshop. 2003. PMID: 12894454 Review. No abstract available.
DNA-repair pathway inhibitors for the treatment of ovarian cancer.
Martinek I, Haldar K, Gaitskell K, Bryant A, Nicum S, Kehoe S, Morrison J. Martinek I, et al. Among authors: nicum s. Cochrane Database Syst Rev. 2010 Jun 16;(6):CD007929. doi: 10.1002/14651858.CD007929.pub2. Cochrane Database Syst Rev. 2010. PMID: 20556786 Free PMC article. Updated. Review.
British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom.
Sundar S, Manchanda R, Gourley C, George A, Wallace A, Balega J, Williams S, Wallis Y, Edmondson R, Nicum S, Frost J, Attygalle A, Fotopoulou C, Bowen R, Bell D, Gajjar K, Ramsay B, Wood NJ, Ghaem-Maghami S, Miles T, Ganesan R. Sundar S, et al. Among authors: nicum s. Int J Gynecol Cancer. 2021 Feb;31(2):272-278. doi: 10.1136/ijgc-2020-002112. Epub 2021 Jan 19. Int J Gynecol Cancer. 2021. PMID: 33468564 Review.
26 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page